Cite
Alhaider R, AlRuthia Y, Almuaythir G, et al. The validation of a newly developed Arabic scale to assess patient-reported side-effects of antineoplastic agents. Saudi Pharm J. 2019;27(6):859-865doi: 10.1016/j.jsps.2019.05.007.
Alhaider, R., AlRuthia, Y., Almuaythir, G., Alsharif, W., Alrasheed, H., Asiri, S., Alghamdi, B., Alsaleh, K., Alosaimi, F. D., Alghadeer, S., & Arafah, A. (2019). The validation of a newly developed Arabic scale to assess patient-reported side-effects of antineoplastic agents. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 27(6), 859-865. https://doi.org/10.1016/j.jsps.2019.05.007
Alhaider, Reem, et al. "The validation of a newly developed Arabic scale to assess patient-reported side-effects of antineoplastic agents." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 27,6 (2019): 859-865. doi: https://doi.org/10.1016/j.jsps.2019.05.007
Alhaider R, AlRuthia Y, Almuaythir G, Alsharif W, Alrasheed H, Asiri S, Alghamdi B, Alsaleh K, Alosaimi FD, Alghadeer S, Arafah A. The validation of a newly developed Arabic scale to assess patient-reported side-effects of antineoplastic agents. Saudi Pharm J. 2019 Sep;27(6):859-865. doi: 10.1016/j.jsps.2019.05.007. Epub 2019 May 22. PMID: 31516328; PMCID: PMC6734156.
Copy
Download .nbib